Balevic, Stephen J. http://orcid.org/0000-0002-4016-1680
Green, Thomas P.
Clowse, Megan E. B.
Eudy, Amanda M.
Schanberg, Laura E.
Cohen-Wolkowiez, Michael
Funding for this research was provided by:
National Institute of General Medical Sciences (US)/National Institute of Child Health and Human Development (2T32GM086330-06)
Derfner Foundation
Duke Health/Private Diagnostic Clinic (ENABLE)
National Institute of Child Health and Human Development (5R01-HD076676-04, 275201000003I)
Rheumatology Research Foundation (233325)
Thrasher Research Fund (236318)
Article History
First Online: 25 September 2018
Compliance with Ethical Standards
:
: Salary and/or research support for this project was provided by the Rheumatology Research Foundation’s Scientist Development Award, the Thrasher Research Fund, the Derfner Foundation, NIGMS/NICHD (2T32GM086330-06), NICHD (5R01-HD076676-04, HHSN275201000003I), and a Duke Health/Private Diagnostic Clinic ENABLE grant. The National Institutes of Health Sponsored open access.
: Stephen J. Balevic receives salary and research support from the National Institute of General Medical Sciences and the National Institute of Child Health and Human Development (2T32GM086330-06, 5R01-HD076676-04, HHSN275201000003I), the Rheumatology Research Foundation, and the Thrasher Research Fund. Michael Cohen-Wolkowiez receives support for research from the National Institutes of Health (5R01-HD076676, HHSN275201000003I), National Institute of Allergy and Infectious Diseases/National Institutes of Health (HHSN272201500006I), US Food and Drug Administration (1U18-FD006298), Biomedical Advanced Research and Development Authority (HHSO1201300009C), and from the industry for the drug development in adults and children (ExternalRef removed). Amanda M. Eudy is a consultant for GlaxoSmithKline and was previously a graduate research assistant for GlaxoSmithKline. Megan E. B. Clowse and Amanda M. Eudy have received independent medical education Grants from GlaxoSmithKline. Thomas P. Green has no conflicts of interest directly relevant to the contents of this article. Laura E. Schanberg receives research support from the National Institutes of Health (5R01-AR063890-02, 1U19AR069522-01, 1U34AR066294), Patient-Centered Outcomes Research Institute (CER-1408-20534, PPRN-1306-04601), Childhood Arthritis and Rheumatology Research Alliance, and Swedish Orphan Biovitrum AB. She participates in the Data Safety and Monitoring Board for UCB and Sanofi. Megan E. B. Clowse serves as a consultant for UCB and AstraZeneca.
: We conducted the study in compliance with the Declaration of Helsinki and the Duke Institutional Review Board approved the protocol.
: All subjects included in the study provided informed consent.